Estados financieros detallados de Profound Medical Corp. (PROF): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Profound Medical Corp. registró ingresos de $16.4M en el último ejercicio fiscal, con un CAGR de 5 años del 17.5%.
Márgenes de los últimos 12 meses: margen bruto 71.7%, margen operativo -184.3%, margen neto -170.9%.
Al precio actual de $5.83, PROF presenta beneficios negativos (P/E no significativo) y un ROE del -62.45%. La capitalización bursátil es de $212M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | $4.9M | $1.9M | $4.2M | $7.3M | $6.9M | $6.7M | $7.2M | $10.2M | $16.4M |
| Coste de Ventas | $188385 | $3.0M | $1.3M | $1.8M | $3.8M | $3.9M | $3.7M | $2.8M | $3.5M | $4.8M |
| Beneficio Bruto | -$188385 | $1.9M | $604815 | $2.4M | $3.5M | $3.0M | $3.0M | $4.4M | $6.7M | $11.6M |
| I+D | $7.4M | $7.7M | $7.5M | $9.4M | $9.9M | $15.3M | $14.7M | $14.4M | $16.2M | $21.0M |
| Generales y Administrativos | $4.2M | $7.8M | $7.9M | $7.9M | $12.4M | $18.0M | $17.9M | $18.6M | $22.0M | $32.6M |
| Gastos Operativos | $16.2M | $19.1M | $15.4M | $17.3M | $22.3M | $33.2M | $35.1M | $33.0M | $38.2M | $53.6M |
| Beneficio Operativo | -$16.2M | -$17.2M | -$14.8M | -$14.9M | -$18.9M | -$30.3M | -$32.1M | -$28.6M | -$31.5M | -$42.0M |
| EBITDA | -$15.6M | -$16.5M | -$19.5M | -$12.5M | -$19.5M | -$28.6M | -$26.6M | -$26.8M | -$25.6M | -$41.4M |
| Gastos por Intereses | $615868 | $1.1M | $755374 | $1.0M | $543000 | $66410 | $167105 | $770000 | 0 | 0 |
| Beneficio Antes de Impuestos | -$16.3M | -$18.7M | -$15.1M | -$15.1M | -$21.6M | -$30.6M | -$28.4M | -$28.7M | -$26.5M | -$43.1M |
| Impuestos | $14054 | $74123 | $169441 | $147000 | $45000 | $105000 | $287000 | -$128000 | -$1903 | $256411 |
| Beneficio Neto | -$12.1M | -$19.1M | -$15.2M | -$15.2M | -$21.6M | -$30.7M | -$28.7M | -$28.6M | -$26.5M | -$43.3M |
| BPA | $-3.93 | $-2.44 | $-1.52 | $-1.39 | $-1.25 | $-1.50 | $-1.38 | $-1.35 | $-1.07 | $-1.43 |
| BPA Diluido | $-3.93 | $-2.44 | $-1.52 | $-1.39 | $-1.25 | $-1.50 | $-1.38 | $-1.35 | $-1.07 | $-1.43 |
| Acciones en Circulación (Diluidas) | $4.2M | $6.1M | $10.0M | $11.1M | $17.3M | $20.5M | $20.8M | $21.2M | $24.8M | $30.2M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $15.5M | $8.8M | $22.5M | $14.8M | $83.9M | $67.1M | $46.5M | $26.2M | $54.9M | $81.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $265946 | $3.6M | $1.5M | $3.3M | $7.4M | $1.4M | $6.3M | $7.3M | $7.0M | $9.9M |
| Inventario | $310113 | $1.1M | $3.6M | $3.7M | $5.3M | $7.4M | $7.9M | $7.0M | $5.8M | $11.3M |
| Activos Corrientes | $16.7M | $14.0M | $37.9M | $22.8M | $97.7M | $77.0M | $62.0M | $41.9M | $69.1M | $104.2M |
| Inmovilizado Material | $709046 | $1.4M | $886439 | $2.2M | $2.3M | $1.9M | $1.7M | $1.6M | $821010 | $225000 |
| Fondo de Comercio | 0 | $2.7M | $2.5M | $2.6M | $2.7M | $2.7M | 0 | 0 | 0 | 0 |
| Activos Intangibles | $195435 | $4.1M | $2.9M | $2.4M | $1.9M | $1.4M | $680000 | $490000 | $261000 | $138000 |
| Activos Totales | $17.6M | $22.2M | $46.4M | $30.1M | $104.6M | $86.7M | $64.4M | $44.0M | $70.2M | $192.9M |
| Cuentas por Pagar | $1.3M | $4.0M | $2.9M | $3.0M | $3.4M | $3.2M | $2.0M | $865000 | $1.3M | $2.1M |
| Deuda a Corto | $2.9M | $4.8M | $983519 | $4.2M | $312000 | $249661 | $523000 | $2.1M | $1.7M | $291731 |
| Pasivos Corrientes | $3.7M | $8.5M | $5.8M | $8.2M | $4.8M | $4.1M | $4.2M | $6.4M | $6.6M | $8.3M |
| Deuda a Largo | $3.8M | $352982 | $10.6M | $5.2M | 0 | 0 | $6.7M | $5.0M | $2.9M | $6.2M |
| Pasivos Totales | $6.6M | $10.9M | $14.6M | $15.7M | $7.3M | $6.1M | $12.4M | $12.7M | $9.8M | $102.0M |
| Reservas | -$53.2M | -$71.8M | -$111.0M | -$101.1M | -$130.0M | -$160.5M | -$189.4M | -$217.4M | -$245.2M | -$394.1M |
| Patrimonio Neto | $11.0M | $11.2M | $26.6M | $14.4M | $97.3M | $80.5M | $52.0M | $31.2M | $60.4M | $91.0M |
| Deuda Total | $4.9M | $4.1M | $8.8M | $11.0M | $1.7M | $1.4M | $8.2M | $7.9M | $5.1M | $6.5M |
| Deuda Neta | -$10.6M | -$4.7M | -$21.9M | -$3.8M | -$82.2M | -$65.7M | -$38.3M | -$18.3M | -$49.8M | -$75.3M |
| Capital Circulante | $13.0M | $5.5M | $32.1M | $14.6M | $92.9M | $72.9M | $57.8M | $35.5M | $62.5M | $95.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$12.1M | -$15.0M | -$15.2M | -$15.6M | -$21.6M | -$30.7M | -$28.7M | -$28.3M | -$27.8M | -$42.6M |
| Amortizaciones | $139132 | $693310 | $1.2M | $1.6M | $1.5M | $1.9M | $1.6M | $929000 | $936000 | $569803 |
| Compensación en Acciones | $745151 | $1.1M | $797485 | 0 | $3.0M | $7.2M | $4.2M | $3.4M | $2.6M | $5.5M |
| Cambio en Capital Circulante | -$151930 | -$501607 | -$990831 | -$3.2M | -$4.6M | -$877000 | -$5.6M | $540000 | $591000 | -$1.7M |
| Flujo de Caja Operativo | -$10.8M | -$15.1M | -$13.4M | -$15.4M | -$20.6M | -$22.4M | -$25.8M | -$22.6M | -$23.5M | -$38.9M |
| Inversiones (CapEx) | -$808842 | -$369502 | 0 | 0 | -$350000 | -$593000 | 0 | 0 | 0 | -$179084 |
| Adquisiciones | 0 | -$423681 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$11.6M | -$12.2M | -$13.4M | -$15.4M | -$20.9M | -$23.0M | -$25.8M | -$22.6M | -$23.5M | -$39.1M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -61.0% | +118.5% | +75.0% | -5.9% | -2.8% | +7.8% | +41.2% | +61.1% | ||
| Crecimiento Beneficio Neto (anual) | -57.2% | +20.2% | +0.1% | -42.0% | -42.0% | +6.6% | +0.3% | +7.3% | -63.6% | |
| Crecimiento BPA (anual) | +37.9% | +37.7% | +8.6% | +10.1% | -20.0% | +8.0% | +2.2% | +20.7% | -33.6% | |
| Cambio en Acciones (anual) | +47.9% | +63.5% | +10.5% | +55.9% | +18.3% | +1.8% | +1.7% | +16.9% | +22.1% | |
| Crecimiento FCF (anual) | -5.0% | -10.3% | -15.0% | -35.5% | -9.7% | -12.4% | +12.4% | -3.7% | -66.5% | |
| Margen Bruto | 38.2% | 31.7% | 57.3% | 47.6% | 43.0% | 45.2% | 60.9% | 65.9% | 70.8% | |
| Margen Operativo | -349.7% | -776.0% | -357.1% | -258.3% | -440.7% | -480.9% | -397.5% | -309.6% | -256.3% | |
| Margen EBITDA | -335.7% | -1018.8% | -300.1% | -266.9% | -416.8% | -398.2% | -372.0% | -251.7% | -252.8% | |
| Margen Neto | -389.4% | -797.9% | -364.7% | -296.0% | -446.7% | -429.1% | -396.8% | -260.4% | -264.4% | |
| Margen FCF | -248.4% | -703.0% | -370.1% | -286.5% | -334.0% | -386.2% | -314.1% | -230.7% | -238.4% | |
| Tasa Impositiva Efectiva | -0.1% | -0.4% | -1.1% | -1.0% | -0.2% | -0.3% | -1.0% | 0.4% | 0.0% | -0.6% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-2.79 | $-1.98 | $-1.34 | $-1.39 | $-1.21 | $-1.12 | $-1.24 | $-1.07 | $-0.95 | $-1.29 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $4.2M | $6.1M | $10.0M | $11.1M | $17.3M | $20.5M | $20.8M | $21.2M | $24.8M | $30.2M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -62.45% |
| Rentabilidad sobre capital invertido | -60.49% |
| Rentabilidad sobre activos | -52.05% |
| Margen bruto | 71.73% |
| Margen operativo | -184.35% |
| Margen neto | -170.92% |
Salud financiera
| Deuda / Patrimonio | 0.15 |
| Ratio corriente | 6.46 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -3.32 | -5.01 | -8.72 | -10.22 | -16.45 | -7.49 | -7.89 | -6.29 | -7.02 | -5.50 |
| P/VC | 4.91 | 6.67 | 5.00 | 10.95 | 3.65 | 2.85 | 4.36 | 5.76 | 3.08 | 2.61 |
| P/V | 0.00 | 15.29 | 69.63 | 37.77 | 48.68 | 33.44 | 33.95 | 24.98 | 18.29 | 14.53 |
| Margen Bruto | 0.0% | 38.2% | 31.7% | 57.3% | 47.6% | 43.0% | 45.2% | 60.9% | 65.9% | 70.8% |
| Margen Operativo | 0.0% | -349.7% | -776.0% | -357.1% | -258.3% | -440.7% | -480.9% | -397.5% | -309.6% | -256.3% |
| Margen Neto | 0.0% | -389.4% | -797.9% | -364.7% | -296.0% | -446.7% | -429.1% | -396.8% | -260.4% | -264.4% |
Empresas relacionadas: ARMP · AVR · CATX · LNSR · MXCT · NNOX · OWLT
Explorar sector: Healthcare · Medical - Devices
Más secciones de PROF: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones